# Insulin Glulisine in Healthy Lean and Obese Subjects

> **NCT00311077** · PHASE1 · COMPLETED · sponsor: **Sanofi**

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Glulisine

## Key facts

- **NCT ID:** NCT00311077
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2004-10
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311077, "Insulin Glulisine in Healthy Lean and Obese Subjects". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00311077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*